elbow luxation simple elbow dislocation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients meeting the following inclusion criteria are eligible for enrolment: 1. Adult men or women aged 18 years and older (with no upper age limit) 2. A simple dislocation of the elbow (i.e., without associated fractures) that can be closed reduced 3. Provision of informed consent by patient.
Exclusion criteria
Exclusion criteria: If any of the following criteria applies, patients will be excluded: 1. Polytraumatized patients 2. Patients with complex, pathological, recurrent or open dislocations 3. Patients with additional traumatic injuries of the affected arm 4. Patients undergoing surgical repair of collateral ligaments of the dislocated elbow joint 5. Patients with an impaired elbow function (i.e., stiff or painful elbow or neurological disorder of the upper limb) prior to the injury 6. Retained hardware around the affected elbow 7. History of operations or fractures involving the elbow 8. Patients with rheumatoid arthritis 9. Likely problems, in the judgment of the attending physician or investigators, with maintaining follow-up (e.g., patients with no fixed address will be excluded) 10. Insufficient comprehension of the Dutch language to understand a rehabilitation program and other treatment information in the judgment of the attending physician. Exclusion of a patient because of enrolment in another ongoing drug or surgical intervention trial will be left to the discretion of the attending surgeon, on a case-by-case basis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quick-DASH (Disabilities of the Arm, Shoulder, and Hand) score | — |
Secondary
| Measure | Time frame |
|---|---|
| May Elbow Performance Index (MEPI) Oxford Elbow Score Pain level at both sides (VAS) Range of Motion of the elbow joint at both sides Rate of secondary interventions Rate of complication rates Health-related quality of life: SF-36 andEQ-5D Radiographic appearance of elbow joint (degenerative changes and ectopic ossifications) Costs Cost-effectiveness | — |
Countries
Netherlands